1. Home
  2. SCPH vs HPAI Comparison

SCPH vs HPAI Comparison

Compare SCPH & HPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • HPAI
  • Stock Information
  • Founded
  • SCPH 2013
  • HPAI 2023
  • Country
  • SCPH United States
  • HPAI Singapore
  • Employees
  • SCPH N/A
  • HPAI N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • HPAI
  • Sector
  • SCPH Health Care
  • HPAI
  • Exchange
  • SCPH Nasdaq
  • HPAI NYSE
  • Market Cap
  • SCPH 274.7M
  • HPAI 234.3M
  • IPO Year
  • SCPH 2017
  • HPAI N/A
  • Fundamental
  • Price
  • SCPH $3.35
  • HPAI $5.80
  • Analyst Decision
  • SCPH Strong Buy
  • HPAI
  • Analyst Count
  • SCPH 2
  • HPAI 0
  • Target Price
  • SCPH $15.00
  • HPAI N/A
  • AVG Volume (30 Days)
  • SCPH 503.0K
  • HPAI 40.2K
  • Earning Date
  • SCPH 11-13-2024
  • HPAI 12-03-2024
  • Dividend Yield
  • SCPH N/A
  • HPAI N/A
  • EPS Growth
  • SCPH N/A
  • HPAI N/A
  • EPS
  • SCPH N/A
  • HPAI N/A
  • Revenue
  • SCPH $30,278,000.00
  • HPAI $29,575,625.00
  • Revenue This Year
  • SCPH $195.62
  • HPAI N/A
  • Revenue Next Year
  • SCPH $145.07
  • HPAI N/A
  • P/E Ratio
  • SCPH N/A
  • HPAI $29.23
  • Revenue Growth
  • SCPH 303.87
  • HPAI 132.36
  • 52 Week Low
  • SCPH $3.08
  • HPAI $3.07
  • 52 Week High
  • SCPH $6.71
  • HPAI $14.74
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 33.76
  • HPAI N/A
  • Support Level
  • SCPH $3.25
  • HPAI N/A
  • Resistance Level
  • SCPH $3.60
  • HPAI N/A
  • Average True Range (ATR)
  • SCPH 0.24
  • HPAI 0.00
  • MACD
  • SCPH -0.05
  • HPAI 0.00
  • Stochastic Oscillator
  • SCPH 19.30
  • HPAI 0.00

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About HPAI HELPORT AI LTD

Helport AI Ltd is a AI technology company based in Singapore dedicated to serving enterprises' customer contact centers with intelligent products, solutions, and a digital platform. Its software, Helport AI Assist (AI Assist), provides tailored AI-powered guidance and oversight for contact center interactions and customer experience, with functions including Agent Assistant, Quality Assurance (QA) Assistant, Supervisor Assistant, and Knowledge Base Assistant.

Share on Social Networks: